Trial intelligence / Profile preview

Isotretinoin and Silymarin in Acne Vulgaris

NCT05666765Phase 4Unknown

Sponsor
Tanta University
Start
Jan 2023
Primary completion
Nov 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of isotretinoin, silymarin in acne vulgaris, sponsored by Tanta University. Status: unknown.

02

Drugs

isotretinoinsilymarin
03

Conditions

acne vulgaris

Beyond the preview

Go deeper on NCT05666765.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05666765.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call